Bringing Gene Supplementation Therapy for PDE6A Associated Retinopathies in Clinical Practice

Bringing Gene Supplementation Therapy for PDE6A-associated Retinopathies into Clinical Practice

Brining Gene Supplementation Therapy fpr PDE6A-associated Retinopathies into Clinical Practice

Chip-Setup in vitro

Die Rolle von ATF6 bei der Entwicklung und Funktion der Zapfen-Photorezeptoren

DRUGSFORD-bis – Towards a clinical trial for hereditary retinal degeneration

DRUGSFORD-bis: Towards a clinical trial for hereditary retinal degeneration

HDAC inhibition protects degenerating cone photoreceptors in vivo

HybrAid – Hybrid solution for enhanced vision-aid for blind people by pharmaceuticals and high-conductive electrical electrodes.

Kohortenstudien bei Patienten mit erblichen Netzhautdegenerationen

Neuroprotection by PARP inhibition

Neuroprotection of Photoreceptor Degeneration

PersonalMed – Personalized medicine: PARP inhibition as a means to save photoreceptors in Pde6a mutant mouse retina, genotype matched to human Retinitis Pigmentosa patients

PhenGenCorr – Phänotyp-Genotypstudien bei Patienten mit erblichen Netzhautdegenerationen

RD Cure WP 5/3 – RD Cure

RD-CURE – Bringing Gene Supplementation Therapy for Inherited PDE6A- and CNGA3-associated Retinopathies into Clinical Practice

RD-CURE – Bringing Gene Supplementation Therapy for PDE6 Associated Retinopathies into Clinical Practice

RD-CURE FP3 – Bringing Gene Supplementation Therapy for Inherited PDE6A- and CNGA3-associated Retinopathies into Clinical Practice: A joint Tübingen-München Project

Retina Ganglion Cells Visual Characterization toolbox

RHO-CURE – Development of pharmacological treatment options to halt retinal degeneration caused by dominant rhodopsin mutations

See-Maus-Funktionst. – Exploring the nature of attainable vision upon restoration of local photoreceptor function

Weiterentwicklung visuell evozierter Potentiale für die Untersuchung der Sehbahn in der Forschung und der klinischen Routine